USA intrauterine Contraceptive Devices (IUD) Market Growing Demand for Copper IUDs and Hormonal IUDs

According to the Precision Business Insights (PBI), the latest report, USA intrauterine Contraceptive devices (IUD) market is expected to be valued at USD 1,072.3 million in 2023, growing at a CAGR of 4.0% over the forecast period. The market is growing significantly in the United States owing to the increasing number of unintended pregnancies and the need for effective contraception methods coupled with the supportive government initiatives and policies that provide free or subsidized IUDs to women from low-income communities and include birth control contraceptives in the Affordable Care Act (ACA). Moreover, the growing inclination towards planned delayed pregnancy and the preference for long-term and reversible birth control options.

View Full Report: https://www.precisionbusinessinsights.com/market-reports/usa-intrauterine-contraceptive-devices-market

The USA Intrauterine Contraceptive Devices (IUD) Market Detailed Segmentation:
Based on the Method, the market is segmented into the following:
• hormonal intrauterine devices
• Copper intrauterine devices

Based on the End-User, the market is segmented into the following:
• Hospitals
• Gynecology Clinics
• Community Health Care Centres
• Others

Based on the Method, the USA intrauterine devices are segmented into hormonal intrauterine devices and copper intrauterine devices. Among these, the copper intrauterine devices are anticipated to account for a large revenue share in the USA intrauterine Contraceptives (IUD) market. Copper-bearing IUDs inhibit pregnancy in a variety of ways. Copper IUDs have an average failure rate of 0.8 percent, according to the Centres for Disease Control and Prevention (CDC). Copper IUDs have been around for a long time, dating back to around 1988, and are older than hormonal IUDs. This IUDs has the added benefit of being able to be used as an emergency contraceptive. Furthermore, because of the lower cost of these devices, IUDs are one of the most often used contraceptive methods in the United States.

According to the Centers for Disease Control and Prevention's 2018 report, 10.3% of women aged 15 to 49 use long-acting reversible contraception (Intrauterine device or contraceptive implant). This number has steadily risen over the years and is projected to continue to rise in the future as more people become aware of the devices' benefits, which is expected to aid the segment's growth over the projection period. For instance, ParaGard, the copper IUD is over 99% effective which has a long-term effect of around 10 years' period. As demonstrated by the National Center for Biotechnology Information (NCBI) copper IUDs have a lower perforation rate than other intrauterine devices. Women with serious health concerns prefer the copper IUD because it reduces the risk of pelvic infection and provides good pregnancy protection without exposing users to exogenous hormones.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=260547

Strategic New Product Launches, Mergers and Acquisitions are the key strategics adopted by market players:
In the recent research the USA intrauterine contraceptive devices (IUD) market further divulge that the key players are intensively adopting strategies such as the launch of novel treatments, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In February 2020, Agile Therapeutics, Inc., obtained consent from U.S. Food and Drug Administration (FDA) for Twirla (levonorgestrel and ethinyl estradiol) transdermal system which is preferred as a method of contraception for use in women of reproductive efficacy with a body mass index (BMI) of 30 kg/m2 for whom a combined hormonal contraceptive is appropriate.

Some of the major key players in the USA intrauterine Contraceptive Devices (IUD) Market are AbbVie, Bayer AG, Copper companies, Viatris Inc., Sebla Pharmaceticals, Cooper Surgical Inc., DKT International, EUROGINE, S.L, Gima Spa, HLL LifecareLTd.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.